Manufacturing
Trust us for unparalleled expertise in pharmaceutical raw materials and pharmaceutical intermediates
About TianmingOur comprehensive range includes Cardiovascular, DiabetesAnti-Tumor, and Anti-Aging Solutions
Explore productsOur commitment to quality and excellence ensures that our pharmaceutical intermediates meet the highest standards
Explore productsSpecializes in providing tailored pharmaceutical intermediates and custom synthesis services to meet your specific requirements
Experience serviceWho We Are
Pharmaceutical raw materials and active pharmaceutical ingredients manufacturers
Tianming Pharmaceutical is a leading company in the research, development, production, and sales of new drugs. Specializing in chemical intermediates, pharmaceutical chemicals, and raw materials, we are trusted active pharmaceutical ingredient suppliers for antibiotics, cardiovascular, diabetes, anti-tumor, anti-aging, and antiviral drugs.
What We Do
Transforming Health with Premium Pharmaceutical Solutions
Advanced Drug R&D
Our team pioneers in discovering and developing new drugs, focusing on antibiotics, cardiovascular, diabetes, anti-tumor, anti-aging, and antiviral treatments.
High-Quality Manufacturing
We maintain rigorous quality control across all production processes, guaranteeing the highest standards for our chemical intermediates and pharmaceutical raw materials.
Comprehensive Global Distribution
We provide active pharmaceutical ingredients, technical consulting, collaborative R&D and other services to global customers to meet diverse market needs.
Our Products
Popular categories
Antiviral
Antiviral products and their intermediates (baloxavir fumarate, nafamostat mesylate, mupiravir, etc.)
Diabetes
Diabetes API and their intermediates (alogliptin, linagliptin, empagliflozin, etc.)
Anti-tumor
Anti-tumor API and their intermediates (ibrutinib, baricitinib, tofacitinib, etc.)
Cardiovascular
Cardiovascular API and their intermediates (LCZ696, AHU377 calcium salt, etc.)
What's News
Latest blog at Tianming
Nitrosamine Impurity Risk in Intermediates: Guide
This guide explains three formation pathways (amine + nitrite reaction, recovered solvent contamination, and shared-equipment cross-contamination), walks through the CPCA classification framework for assessing risk levels, and provides five questions every procurement team should ask their intermediate supplier — plus four red flags to spot on a COA.
Intermediate Retest Date vs Expiry Date: What Buyers Must Know
This guide clarifies the three terms (retest date, expiry date, shelf life) with ICH definitions, explains how manufacturers assign retest periods using a risk-based stability framework, and gives you five questions to ask any supplier — plus four red flags to watch for on COA date labels.
Intermediate Pricing: 6 Cost Drivers Explained
A manufacturer’s guide to the six cost layers behind pharmaceutical intermediate pricing—raw materials, synthesis yields, chiral chemistry, purification, waste treatment, and scale—helping buyers evaluate competing quotes and identify hidden risks.
